Proteins in Action – Haemoglobin: Cooperativity, Allostery & Physiological Modulation

Conformational Basis of Oxygen Binding

  • O_2 binding flattens haem, pulls His F8 & helix F toward the haem pocket.
  • Transition between T (low affinity)T \text{ (low affinity)} and R (high affinity)R \text{ (high affinity)} states underlies function.
  • Any factor that keeps helix F away lowers O_2 affinity.

Cooperativity & Allostery

  • Tetrameric Hb shows positive cooperativity: first O_2 bound shifts equilibrium TRT \leftrightarrow R, increasing affinity at remaining sites.
  • Cooperativity is most evident when allosteric inhibitors (e.g.
    BPG, CO_2, H\^+) stabilise the TT state; “stripped” Hb (no inhibitors) is largely in RR and shows little cooperativity.

Major Allosteric Effectors

  • 2,3-Bisphosphoglycerate (BPG)
    • Binds central cavity of deoxy-Hb via electrostatic contacts.
    • Stabilises TT state → lowers O_2 affinity.
    • [BPG] rises in peripheral tissues & at high altitude, promoting O_2 release.
  • CO_2 & H\^+ (Bohr effect)
    • CO_2 forms carbamates; H\^+ protonates residues → both favour TT state.
    • Result: reduced O_2 affinity in metabolically active/acidic tissues.

Binding Curves & Physiological Function

  • Myoglobin: hyperbolic curve; saturated at low pO<em>2pO<em>2; releases O_2 only when pO</em>2pO</em>2 is very low.
  • Haemoglobin: sigmoidal curve due to cooperativity + allostery; loads O_2 in lungs (high pO<em>2pO<em>2), releases in tissues (low pO</em>2pO</em>2).

Foetal vs Adult Haemoglobin

  • Foetal Hb (HbF: (\alpha2\gamma2)) replaces β with γ chains.
  • γ chain has Ser instead of His in BPG site → weaker BPG binding, higher O_2 affinity.
  • Enables O_2 transfer across placenta; post-natal switch to adult HbA ((\alpha2\beta2)).

Sickle Cell Haemoglobin (HbS)

  • Mutation: β6GluVal\beta6\,\text{Glu} \rightarrow \text{Val} creates hydrophobic patch.
  • Deoxy-HbS polymerises → erythrocyte “sickling”, vaso-occlusion; nonetheless confers malaria resistance.
  • Therapies:
    • CRISPR (CASGEVY) reactivates HbF; curative but costly & resource-intensive.
    • Voxelotor stabilises RR state, raises O_2 affinity; oral option where gene therapy impractical.

Summary Points

  • O_2 binding induces conformational change, driving TRT \rightarrow R shift.
  • BPG, CO_2, H\^+ are key allosteric inhibitors that lower Hb O_2 affinity and reveal cooperativity.
  • Foetal adaptations and pathological variants (HbS) modify these mechanisms for distinct physiological outcomes.